This inventor holds 1 USPTO granted patent. Top assignees: Merck Sharp + Dohme B.v., Merck Sharp + Dohme Corp.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021
Title: The Innovative Contributions of Peter Bakker
Introduction
Peter Bakker is a notable inventor based in Zeist, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable drug formulations. His work has implications for the treatment and prevention of HIV and AIDS.
Latest Patents
Peter Bakker holds a patent for a formulation for parenteral administration. This innovative invention provides pharmaceutical formulations for a long-acting injectable drug product comprising a suspension of doravirine. The drug product is designed for parenteral administration via intramuscular or subcutaneous routes. It can be utilized for the treatment or prophylaxis of HIV infection, as well as for the treatment, prophylaxis, or delay in the onset of AIDS or AIDS-related complex.
Career Highlights
Throughout his career, Peter Bakker has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Peter Bakker has collaborated with several professionals in his field. Notable coworkers include Sachin Mittal and Irina Kazakevich. Their collective efforts have further advanced the research and development of pharmaceutical innovations.
Conclusion
Peter Bakker's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare outcomes. His innovative work in injectable drug products is vital for the treatment and prevention of serious health conditions such as HIV and AIDS.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile